Tare, a credit marketplace providing end-to-end infrastructure for originating, managing and financing private credit assets, has raised $13.25 million in seed funding led by Blockchain Capital.
Sling Therapeutics has raised $123 million in Series C funding led by Forbion, TPG Life Sciences Innovations and Sectoral Asset Management, to advance its oral therapy linsitinib for thyroid eye disease.
Bay Area biotech Circle Pharma has raised $92.5 million in Series E funding from The Column Group, RA Capital Management and Eli Lilly, extending a strong week for global biotech venture financing.
Activate, the venture firm led by Aakrit Vaish, has closed its maiden fund at $105 million, positioning itself to back early-stage AI startups at a moment when Indian AI investing continues to accelerate.
VerifAIX, an AI-native semiconductor verification startup, has raised $5 million in seed funding to scale its engineering teams and expand its chip-verification platform for fabless design houses.
TRUE ARTIS, an integrated Indian aesthetic healthcare and surgical platform, has raised Rs 11.4 crore in a seed round led by Zeropearl VC, backed by healthcare investors and operators including V3 Ventures' Arjun Vaidya, as it expands across Delhi NCR.
Jinjing Technology, also known as Goldenscope Tech, has raised RMB 300 million in Series B funding to scale production of its electron-beam lithography systems and cathodoluminescence imaging equipment used in semiconductor research.
Noetive, an AI startup building an industrial world model for factories, logistics sites and construction environments, has emerged from stealth with $41 million in seed funding led by Eclipse, backed by Meta CTO Andrew Bosworth and Airbnb CTO Ahmed Al-Dahle.
Japanese manufacturing-technology company CADDi has raised ¥17.7 billion in Series D funding, taking cumulative equity financing past ¥36 billion and valuing the company at ¥182 billion, with Toyota-backed Woven Capital and Salesforce Ventures joining as new investors.
AI biotechnology company Anew Labs has raised $290 million in its first external financing round, backed by a consortium of leading Chinese venture and growth-equity investors, at a valuation of $1.5 billion.